SINO BIOPHARMACEUTICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.88 HKD | +6.67% |
|
+11.63% | -17.00% |
| 04-30 | Wall Street, Earnings, Federal Reserve Roil Asian Stock Markets | MT |
| 04-30 | Sino Biopharmaceutical Limited Announces Approval for Marketing of Category 1 Unecritinib Fumarate Capsules | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.33B | ||||||
| 699B | ||||||
| 571B | ||||||
| 364B | ||||||
| 326B | ||||||
| 286B |
